Menu
Menu
What’s the biggest challenge facing the cannabis industry right now, and how are you and/or your company addressing it?
The biggest challenge is broader acceptance.
Cannabis has made major progress, but the industry is still working to earn credibility with regulators, physicians, institutions, and mainstream consumers. For that to happen, we need to move beyond hype and continue building around quality, safety, research, standardization, and responsible use.
The next phase of acceptance will come from showing that cannabinoids can be understood, studied, and applied in credible ways. That means better science, better manufacturing standards, better education, and a more mature conversation about where these compounds can fit into health, wellness, and society.
Where do you see the most exciting opportunity for growth and innovation in cannabis?
The most exciting opportunity is in medical and therapeutic markets.
I believe the biggest future category for cannabis and cannabinoids is health-related use. We are still in the early stages of understanding how different cannabinoids work, what specific applications they may support, and how they can be developed into more trusted products and platforms.
There is a major opportunity to legitimize cannabinoids through research, clinical validation, intellectual property, and better product standardization. That is where I think the industry can create real long-term value: not just by expanding access, but by proving where cannabinoids can make a meaningful difference.
What’s one piece of advice you would give to someone looking to break into the cannabis industry?
Understand that cannabis is still a frontier market.
You need a strategy that can work in the industry as it exists today while still building toward the industry you believe will exist tomorrow. Regulations change, capital markets shift, consumer behavior evolves, and the rules are often unclear.
That means you need to be adaptable, but you also need conviction. If you are only chasing the current market, you can get trapped by short-term thinking. But if you are only building for the future, you may not survive long enough to see that future arrive.
The key is learning how to operate in both realities at the same time.
What is the most important thing you have learned from your experiences in the cannabis industry?
The most important thing I have learned is to embrace uncertainty.
In cannabis, uncertainty is part of the operating environment. The industry does not always provide a fixed foundation to build on. In many cases, you have to help lay that foundation yourself.
That uncertainty can be frustrating, but it can also become a tool. It forces you to develop pattern recognition, make effective pivots, and adapt quickly when the market changes. The companies and people who last in this industry are the ones who can keep learning, keep adjusting, and keep moving forward without losing sight of the bigger picture.
What do you want your legacy to be as it relates to the cannabis industry?
I made a conscious decision more than 12 years ago to build in this industry and be part of the transition from prohibition to a mature industry.
Over time, I have come to see cannabis as more than a single industry. It is an emerging economy made up of agriculture, science, medicine, manufacturing, consumer products, policy, and culture. Being part of that evolution has shaped how I think about the work and the responsibility that comes with it.
My hope is that my legacy is tied to helping cannabinoids earn credibility in health and wellness. I have seen firsthand the therapeutic potential of these compounds, and I believe the research is still only beginning to show how important they may become.
If I can contribute to moving cannabinoids from the margins into a more trusted, evidence-based future, that would be a legacy I would be proud of.